Skip to main content
Log in

Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel diseas

  • Intestinal Disorders, Inflammatory Bowel Disease, Immunology, And Microbiology
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

A link between inflammation of the colon in inflammatory bowel disease (IBD) and the increased risk of colon cancer in ulcerative colitis (UC) may be provided by growth factor receptor genes. Their expression may be altered in response to growth factors present in the mucosa, and this, in turn, may induce further genetic changes, linked to carcinogenesis, in the cells of the colonic epithelium. To test this hypothesis, we assayed steady-state levels of eight growth factor receptor mRNAs in colonic epithelial cells of IBD patients and controls. Four of these genes (EGF-R, IGFI-R, CSF1-R, andPDGF-R-β) were expressed in epithelial cells, whereas four (erbB-2, erbB-3, NGF-R, andmet) were not. The level of the former in involved or uninvolved IBD was considerably lower than in normal epithelial cells from either sporadic colon cancer or diverticulitis patients. In contrast, expression was much higher in IBD patients with colon tumors than in active chronic IBD. The level of PDGF-R-β mRNA was two- to fourfold higher in involved than in uninvolved areas of the colons of two UC patients, but not in one Crohn's disease patient. Message abundance of its ligand,PDGF-β, however, was the same in paired UC samples. The pattern of expression ofPDGF-β andcripto was identical to that ofEGF-R, whereas the level of mRNA of amphiregulin was the same in active chronic IBD and IBD patients with tumors. A fourth growth factor,Kfgf, was not expressed. Increased levels of PDGF-R-β mRNA in involved UC relative to uninvolved UC may be related to the disease process in UC. Decreased expression of growth factor- and growth factor receptor-encoded mRNA in active chronic IBD may be related to the disease process, or it may be an effect of steroid therapy undergone by these patients. Enhanced expression of these genes in IBD patients with tumors compared to those without tumors suggests that this may be a marker for development of colon cancer in IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Macdermott RP, Stenson WF: Alterations of the immune system in ulcerative cotitis an Crohn's disease. Adv Immunol 42:285–328, 1988

    PubMed  Google Scholar 

  2. Collins RH Jr, Feldman M, Fordtran JS: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: A critical review. New Engl J Med 316:1654–1658, 1987

    PubMed  Google Scholar 

  3. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M: Detection of high incidence ofK-ras oncogenes during human colon tumorigenesis. Nature 327:298–303, 1987

    PubMed  Google Scholar 

  4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakarnura Y, White R, Smits AMM, Bos JL: Genetic alterations diring colorectal-tumor development. N Engl J Med 319:525–532, 1988

    PubMed  Google Scholar 

  5. Burmer GC, Loeb LA: Mutations in theKRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 86:2403–2407, 1989

    PubMed  Google Scholar 

  6. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS:c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 99:416–420, 1990

    PubMed  Google Scholar 

  7. Meltzer SJ, Mane SM, Wood PK, Resau JH, Newkirk C, Terzakis JA, Korelitz BI, Weinstein WM, Needleman SW: Activation ofc-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res 50:3627–3630, 1990

    PubMed  Google Scholar 

  8. Delattre P, Olschwang S, Law DJ, Melot T, Remvikos Y, Salmon RJ, Sastre K, Validre P, Feinberg AP, Thomas G: Multiple genetic alterations distinguish distal from proximal colorectal cancer. Lancet 2:353–356, 1989

    PubMed  Google Scholar 

  9. Burmer GC, Crispin DA, Kolli VR, Haggitt RC, Kulander BG, Rubin CE, Rabinovitch PS: Frequent loss of ap53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun 3:167–172, 1991

    PubMed  Google Scholar 

  10. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, McDaniel T, Newkirk C, Resau JH, Meltzer SJ: Loss of heterozygosity affecting thep53, Rb, andmcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 52:741–745, 1992

    PubMed  Google Scholar 

  11. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE: Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of ap53 allele. Gastroenterology 103:1602–1610, 1992

    PubMed  Google Scholar 

  12. MacDonald TT, Spencer J: Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 167:1341–1349, 1988

    PubMed  Google Scholar 

  13. Shanahan F, Targan S: Mechanisms of tissue injury in inflammatory bowel disease.In Current Topics in Gastroenterology: Inflammatory Bowel Disease. RP MacDermott, WF Stenson (eds). New York, Elsevier, 1982, pp 77–93

    Google Scholar 

  14. Mayer L, Shlien R: Evidence for function of la molecules on gut epithelial cells in man. J Exp Med 166:1471–1483, 1987

    PubMed  Google Scholar 

  15. Mayer L, Eisenhardt D: Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest 86:1255–1260, 1990

    PubMed  Google Scholar 

  16. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159, 1987

    PubMed  Google Scholar 

  17. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982

    Google Scholar 

  18. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418–425, 1985

    Google Scholar 

  19. Bargmann CI, Hung MC, Weinberg RA: Theneu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226–230, 1986

    PubMed  Google Scholar 

  20. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA: Isolation and characterization ofERBB3, a third member of theERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193–9197, 1989

    PubMed  Google Scholar 

  21. Martin-Zanca D, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319:743–748, 1986

    PubMed  Google Scholar 

  22. Dean M, Park M, Le Beau MM, Robins TS, Diaz MO, Rowley JD, Blair DG, Vande Woude GF: The humanmet oncogene is related to the tyrosine kinase oncogenes. Nature 318:385–388, 1985

    PubMed  Google Scholar 

  23. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A: Structural alteration of viral homologue of receptor proto-oncogenefms at carboxyl terminus. Nature 320:277–280, 1986

    PubMed  Google Scholar 

  24. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramanchandran J, Fujita-Yamaguchi Y: Insulinlike growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503–2512, 1986

    PubMed  Google Scholar 

  25. Gronwald RGK, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, Murray MJ: Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: Evidence for more than one receptor class. Proc Natl Acad Sci USA 85:3435–3439, 1988

    PubMed  Google Scholar 

  26. Josephs SF, Ratner L, Clarke MF, Westin EH, Reitz MS, Wong-Staal F: Transforming potential of humanc-sis nucleotide sequences encoding platelet-derived growth factor. Science 225:636–639, 1984

    PubMed  Google Scholar 

  27. Delli Bovi P, Basilico C: Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad Sci USA 84:5660–5664, 1987

    PubMed  Google Scholar 

  28. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 10:1969–1981, 1990

    PubMed  Google Scholar 

  29. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG: Molecular characterization of a gene of the “EGF family” expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8:1987–1991, 1989

    PubMed  Google Scholar 

  30. Dono R, Montouri N, Rocchi M, De Ponti-Zilli L, Ciccodicola A, Persico MG: Isolation and characterization of theCRIPTO autosomal gene and its X-linked related sequence. Am J Hum Genet 49:555–565, 1991

    PubMed  Google Scholar 

  31. Fort P, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431–1442, 1985

    PubMed  Google Scholar 

  32. Alexander RJ, Buxbaum JN, Raicht RF: Enhanced expression of oncogene-encoded mRNA in a rat model of colon cancer. Am J Med Sci 301:238–245, 1991

    PubMed  Google Scholar 

  33. Selden RF: Analysis of RNA by northern hybridization.In Current Protocols in Molecular Biology. FM Ausubel, R Brent, RE Kingston, DD Moore, JG Seidman, JA Smith, K Struhl (eds). New York, Wiley Interscience, 1987, Section 4.9

    Google Scholar 

  34. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS: Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 88:7792–7796, 1991

    PubMed  Google Scholar 

  35. Liu C, Park M, Tsao MS: Overexpression ofc-met protooncogene but not epidermal growth factor receptor orc-erbB-2 in primary human colorectal carcinomas. Oncogene 7:181–185, 1992

    PubMed  Google Scholar 

  36. Yasui W, Samiyashi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 48:137–141, 1988

    PubMed  Google Scholar 

  37. Harris AL, Neal DE: Epidermal growth factor and its receptor in human cancer.In Growth Factors and Oncogenes in Breast Cancer. M Sluyser (ed). Chichester, England, Ellis Horwood, 1987, pp 60–90

    Google Scholar 

  38. Wright C, Angus B, Nicholson S, Sainsbury RC, Cairns J, Gullick WJ, Kelly P, Harris AL, Wilson Horne CH: Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 49:2087–2090, 1989

    PubMed  Google Scholar 

  39. Foekens JA, Portengen H, Janssen M, Klijn JGM: Insulin-like growth factor 1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer. Cancer 63:2139–2147, 1989

    PubMed  Google Scholar 

  40. Rubin K, Tingstrom A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, Claesson-Welsh L, Heldin CH, Fellstrom B, Terracio L: Induction ofβ-type receptors for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions. Lancet 1:1353–1356, 1988

    PubMed  Google Scholar 

  41. Rubin K, Terracio L, Ronnstrand L, Heldin CH, Klareskog L: Expression of platelet-derived growth factor receptors is induced on connective tissue cells during chronic synovial inflammation. Scand J Immunol 27:285–294, 1988

    PubMed  Google Scholar 

  42. Reueterdahl C, Tingstrom A, Terracio L, Funa K, Heldin CH, Rubin K: Characterization of platelet-derived growth factorβ-receptor expressing cells in the vasculature of human rheumatoid synovium. Lab Invest 64:321–329, 1991

    PubMed  Google Scholar 

  43. Friedman SL, Arthur MJP: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium: Direct enhancement of matrix synthesis and stimulation of cel proliferation via induction of platelet-derived growth factor receptors. J. Clin Invest 84:1780–1785, 1989

    PubMed  Google Scholar 

  44. Friedman SL: The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 328:1828–1835, 1993

    PubMed  Google Scholar 

  45. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesengial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560–6564, 1991

    PubMed  Google Scholar 

  46. Roberts WM, Look AT, Roussel MF, Sherr CJ: Tandem linkage of human CSF-1 receptor (c-fms) and PDGF receptor genes. Cell 55:655–661, 1988

    PubMed  Google Scholar 

  47. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, Shipley GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 52:3224–3227, 1992

    PubMed  Google Scholar 

  48. Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T: Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci USA 83:3997–4001, 1986

    PubMed  Google Scholar 

  49. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T: High incidence of coamplification ofhst-1 andint-2 genes in human esophageal carcinomas. Cancer Res 49:5505–5508, 1989

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This research was supported in part by grants (to L.M.) AI-23504, AI-24671, and DK-44156 from the National Institutes of Health and by a grant (to R.F.R.) from the Division of Sponsored Research, Marion Merrell Dow, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexander, R.J., Panja, A., Kaplan-Liss, E. et al. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel diseas. Digest Dis Sci 40, 485–494 (1995). https://doi.org/10.1007/BF02064355

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02064355

Key Words

Navigation